Navigation Links
Arcion Therapeutics' Topical Gel Candidate, ARC-4558, Demonstrates Significant Pain Reduction in Phase 2b Trial for Painful Diabetic Neuropathy (PDN)
Date:7/20/2010

ents in the study applied ARC-4558 0.1% gel or placebo to the affected area three times a day (3.9 mg clonidine per day) for a 12-week treatment period. Patients were able to continue taking a stable dose of their existing pain medications. The primary endpoint of the study related to the change in pain at week 12 compared to baseline measured by the numerical pain rating scale (NPRS).  

About ARC-4558

ARC-4558 is a 0.1% gel formulation of clonidine hydrochloride (HCL) for topical administration to the painful area in order to manage the neuropathic pain associated with painful diabetic neuropathy (PDN).  Topical clonidine, through its agonist effects on alpha2 (a2)-adrenergic receptors, is believed to reduce pain in PDN via local actions on the nociceptors that innervate the affected skin. Based on the results of clinical trials to-date, Arcion believes that ARC-4558 has a level of efficacy comparable to systemic therapies in the target population, but with substantially fewer side effects. The 0.1% gel formulation avoids the treatment area limitations and undesirable aesthetic and skin reaction issues associated with analgesic patches. Furthermore, the ARC-4558 gel has been shown to provide analgesia without numbing or anesthetizing the skin.

About Painful Diabetic Neuropathy (PDN)

Neuropathy is a common complication of diabetes mellitus. According to 2008 estimates by the Centers for Disease Control and Prevention, nearly 18 million people in the United States are diagnosed with diabetes. Given a conservative estimate that 15% of people with diabetes have painful neuropathies, approximately 2.7 million Americans experience PDN. Patients with PDN often experience debilitating pain symptoms that affect day-to-day functioning and quality of life.  How diabetes causes a
'/>"/>

SOURCE Arcion Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Anesiva Announces Merger With Arcion Therapeutics Will Not be Completed
2. Arcion Therapeutics Topical Pain Candidate, ARC-4558, Significantly Reduces Pain Caused by Diabetic Neuropathy
3. Elusys Therapeutics and Lonza Extend Manufacturing Agreement for Anthim, a New Anthrax Treatment in Late-Stage Development
4. Silence Therapeutics and AstraZeneca Extend siRNA Development Collaboration
5. Nile Therapeutics Completes Dosing of Phase II Study
6. Cornerstone Therapeutics Announces Management Change
7. Nonconformity of NOV002 Used in Phase 3 NSCLC Trial Sponsored by Novelos Therapeutics, Inc to NOV002 (Glutoxim(R)), Used in Phase 1/2 NSCLC and all Previous Trials
8. InteKrin Therapeutics Presented Phase 2b Clinical Data at the 2010 American Diabetes Association Annual Meeting, Demonstrating Improved Glycemic Control in Patients with Type 2 Diabetes Without Causing the Edema Seen with Pioglitazone
9. Global Melanoma Therapeutics Industry
10. Tolera Therapeutics Granted Orphan Drug Designation for Treatment of Type 1 diabetes mellitus
11. TransGenRx Protein Therapeutics Technology to Support Research Related to Protein-Based HDL Therapies at Esperion Therapeutics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... , July 30, 2014  Packaging Coordinators, Inc. ... definitive agreement to acquire Penn Pharmaceutical Services Limited (Penn ... in the United Kingdom ... Hope, Pennsylvania and Tokyo ... services, including Clinical and Commercial dosage form manufacturing, as ...
(Date:7/30/2014)... 30, 2014   Medical Equipment Solutions, Corp. ... a Department of Defense (US Army) contract valued at ... mobile MRI diagnostic machine and technical support staffing. As ... the Small Business Administration (SBA), Medical Equipment is proud ... the latest medical diagnostic equipment. The SBA 8-A certification ...
(Date:7/30/2014)... 2014 Die Apex Medical Corporation ... Bereich Atemtherapie- und Druckzonenprodukte, gibt bekannt, dass ... Deutschland anfechten werden. Dieses hat entschieden, dass ... von ResMed verletze. Apex weist darauf hin, ... verschiedene Patente von ResMed Anfechtungen wegen Nichtigkeit ...
Breaking Medicine Technology:PCI Announces Definitive Agreement to Acquire Penn Pharma 2PCI Announces Definitive Agreement to Acquire Penn Pharma 3PCI Announces Definitive Agreement to Acquire Penn Pharma 4PCI Announces Definitive Agreement to Acquire Penn Pharma 5Medical Equipment Solutions Corp. Awarded $2 Million contract To Service DoD 2Apex setzt seinen Kampf gegen Patente für einen freien Wettbewerb fort 2Apex setzt seinen Kampf gegen Patente für einen freien Wettbewerb fort 3
(Date:7/30/2014)... The report entitled “Global Pulse Oximetry ... the market dynamics and changing trends in the global ... forecasted market sizing of the global pulse oximetry market ... of the same. It further captures the global market ... the market. Further, the report discusses the domestic market ...
(Date:7/30/2014)... California (PRWEB) July 30, 2014 The ... 46.05 billion by 2020, according to a new study ... invasive procedures and the growing prevalence of diabetes, obesity ... over the forecast period. In addition, the introduction of ... market penetration of minimally invasive procedures in emerging Asian ...
(Date:7/30/2014)... All the children at Father’s Home come from ... exploitation tend to mar their respective psychosocial development. There ... youth development has underpinnings in a healthy adolescence and ... in the foreseeable future, would assist in developing the ... mere presence of Foundation members in that remote location ...
(Date:7/30/2014)... Thompson HealthDay Reporter TUESDAY, ... and vegetables are vital to good health and a long ... five servings of fruits and vegetables each day, additional daily ... suggests. The human body may only be able to ... day, limiting its ability to absorb important nutrients from extra ...
(Date:7/30/2014)... FL (PRWEB) July 30, 2014 ... doctoral candidate Renee Gordon and biochemistry professor Ngozi ... to conduct research as Fulbright Scholars. The prestigious ... education exchange program that awards grants to students, ... and conduct research abroad. Both Gordon and Ugochukwu ...
Breaking Medicine News(10 mins):Health News:Global Pulse Oximetry Market 2018 Opportunities and Trends Now Available at MarketReportsOnline.com 2Health News:Global Pulse Oximetry Market 2018 Opportunities and Trends Now Available at MarketReportsOnline.com 3Health News:Global Catheters Market - Industry Size, Trends, Analysis, Growth, Players, Outlook and Forecast Research Report from 2014 to 2020: Grand View Research, Inc 2Health News:Global Catheters Market - Industry Size, Trends, Analysis, Growth, Players, Outlook and Forecast Research Report from 2014 to 2020: Grand View Research, Inc 3Health News:The Edusei Foundation Donates Food and Assorted Items to the Fathers’ Home Care Ministries in Takoradi, Ghana 2Health News:Fruits, Veggies May Have Their Limits in Boosting Lifespan 2Health News:Fruits, Veggies May Have Their Limits in Boosting Lifespan 3Health News:FAMU Professor and Engineering Student Named Fulbright Scholars 2Health News:FAMU Professor and Engineering Student Named Fulbright Scholars 3
... 6-7, Mandarin Oriental, Washington, D.C., ARLINGTON, ... industry,CEOs, along with top Wall Street analysts ... other government officials, will headline the,Generic Pharmaceutical ... 2007. The conference, "Generics: Prescription for Affordable,Health ...
... ATRC ), a medical device company focused on ... David J. Drachman, President and Chief Executive Officer, is,scheduled ... at the Four Seasons Hotel in Boston on Wednesday, ... cast and recording of the presentation will be available ...
... Italian study , , THURSDAY, Aug. 30 (HealthDay News) -- Stroke ... dying in the next year compared to those who stayed ... of other studies have shown the benefits of using statins ... the Italian study comes on the heels of a Spanish ...
... have no genetic blueprint to classify melanomas, a lethal form ... deeply the growth has invaded underlying skin tissue. The ... cancer, but some patients defy the odds and survive with ... patients with cancers of the same invasion depth and appearance ...
... reduce or prevent allergic reactions, group suggests , THURSDAY, ... people with seasonal allergies may suffer oral allergy syndrome ... pollen proteins from weeds, grass and trees and similar ... symptoms of OAS -- also known as pollen-food syndrome ...
... be behind ability to know the tone of a musical ... do-it-yourself study has found evidence for a possible genetic basis ... of a musical note without other notes as reference, researchers ... sibling of a person with absolute pitch also has absolute ...
Cached Medicine News:Health News:GPhA's 2007 Annual Policy Conference Features Top Generic Industry CEOs; FDA, Government Officials; Wall Street Analysts 2Health News:AtriCure to Present at Thomas Weisel Partners 2007 Healthcare Conference 2Health News:Stopping Statins After Stroke Doubles Death Risk 2Health News:Stopping Statins After Stroke Doubles Death Risk 3Health News:Gene signature spells poor outcome 2Health News:Pollen, Fruits, Veggies Help Trigger Oral Allergy Syndrome 2Health News:Is Perfect Pitch All in the Genes? 2
Used in conjunction with the E5381 700 Circling Band (240 style). Indications: Narrow scleral bed. Overall length: 100 mm, 3.9 inches....
2.5 mm x 0.6 mm. Overall length: 122 mm, 4.8 inches....
Used in conjunction with the E5381 600 Circling Band (40 style). Indications: Massive retinal breaks. Inner diameter: 26 mm....
Concave inner surface to conform to the globe. Used in conjunction with the E5381 600 Circling Band (40 style). Indications: Wide scleral bed. Outside diameter 30.2 mm....
Medicine Products: